S. Alavi

PLGA nanoparticles co-loaded with resveratrol and doxycycline for dual-action periodontal therapy: in vitro and in vivo evaluation.

Results demonstrate PLGA-DOX/RV as a potent localized therapy for periodontitis as well as demonstrating its ability to reduce alveolar bone loss in vitro and in vivo.